Biomarin Pharmaceutical (BMRN) Shares Outstanding (2009 - 2026)
Biomarin Pharmaceutical's Shares Outstanding came in at 193.42 million for Q2 2026, up 0.8% from 191.91 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Shares Outstanding (2009 - 2026) Analysis & Trends
For FY2025, Biomarin Pharmaceutical's Shares Outstanding was 191.79 million, up 0.9% from FY2024.
- Shares Outstanding has increased in each of the last 16 years, with a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 190.03 million in FY2024 (+1.2%), 187.83 million in FY2023 (+1.4%), 185.27 million in FY2022 (+1.3%) and 182.85 million in FY2021 (+1.1%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q2 2009.
- Year-over-year, Shares Outstanding has increased for 65 consecutive quarters, with growth averaging 1.0% over the last eight quarters.
- Business Quant data shows BMRN's Shares Outstanding at 192.5 million (Q1 2026), 191.79 million (Q4 2025) and 192.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 193.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 193.42 Mn |
| Mar 31, 2026 | 192.50 Mn |
| Dec 31, 2025 | 191.79 Mn |
| Sep 30, 2025 | 192.03 Mn |
| Jun 30, 2025 | 191.91 Mn |
| Mar 31, 2025 | 190.97 Mn |
| Dec 31, 2024 | 190.03 Mn |
| Sep 30, 2024 | 190.43 Mn |
| Jun 30, 2024 | 190.11 Mn |
| Mar 31, 2024 | 188.87 Mn |
| Dec 31, 2023 | 187.83 Mn |
| Sep 30, 2023 | 188.22 Mn |
| Jun 30, 2023 | 187.95 Mn |
| Mar 31, 2023 | 186.67 Mn |
| Dec 31, 2022 | 185.27 Mn |
| Sep 30, 2022 | 185.60 Mn |
| Jun 30, 2022 | 185.25 Mn |
| Mar 31, 2022 | 183.99 Mn |
| Dec 31, 2021 | 182.85 Mn |
| Sep 30, 2021 | 183.21 Mn |
API Access
Biomarin Pharmaceutical Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();